Screening and treatment of TB/HIV co-infection in Jilin Province from 2016 to 2022
Objective To understand the screening and treatment information of tubercle bacilli(TB)/human immunode-ficiency virus(HIV)co-infection in Jilin from 2016 to 2022,to provide a reference for further improving the control and prevention of TB/HIV co-infection.Methods The descriptive statistical method was used to analyze the annual reports of TB/HIV co-infection prevention and treatment management in Jilin from 2016 to 2022.Results During the period,a total of 9 107 new cases of HIV/AIDS were detected,among whom 8 099(88.93％)were screened for tuberculosis,and 108 were diagnosed with TB/HIV co-infection,with a co-infection rate of 1.33％(108/9 107).Among the 49 667 cases of HIV/AIDS who had been followed up,41 472(83.50％)were screened for tuberculosis,and 101 were diagnosed with TB/HIV co-infection,with a co-infection rate of 0.20％.Of the 70 474 newly registered cases of tuberculosis,27 045(38.38％)were tested for HIV antibody,and 29 were tested positive,with a positive rate of 0.11％.The tuberculosis de-tection rate(1.33％)in newly diagnosed cases of HIV/AIDS was higher than that(0.20％)in available follow-up cases of HIV/AIDS.and they also had higher HIV positive detection rate than available follow-up cases of tuberculosis(x2=315.79,P＜0.01).A total of 238 cases were detected with co-infection of TB/HIV,and the rates of receiving anti-retrovi-ral and anti-tuberculosis treatment,anti-tuberculosis treatment,anti-retroviral treatment were 63.45％,5.46％and 17.23％,respectively.Conclusion The screening for both TB and HIV infections can effectively promote the early detec-tion of TB/HIV co-infection.Recommendations for future control and prevention of TB/HIV co-infection are as follows:strengthening inter-department cooperations and the screening for TB and HIV infections to improve the detection rate of TB/HIV co-infection;giving priority to the publicity of relevant control and prevention measures in focus groups;mobili-zing those living with HIV/AIDS with latent TB infection to receive tuberculosis preventive therapy to reduce the risk of tu-berculosis and improve the control of TB/HIV co-infection.
万方数据
